Vitrea Health

What Vitrea Health does

Vitrea Health is a U.S. direct-to-consumer health-tech startup founded in 2023 and headquartered in Farmington Hills, Michigan. The company sells once-a-day eye health dietary supplements — branded as Vitrea Spectrum® and Vitrea Vision Macular Restore — targeted at adults concerned about age-related macular degeneration (AMD) and broader age-related declines in macular health. Vitrea's core proposition is a broader-spectrum formulation than traditional AREDS 2 supplements, combining multiple carotenoids, antioxidants, taurine, and other nutrients intended to cross the blood-retinal barrier, filter harmful blue light, and counter oxidative stress; the company positions the formula as the output of collaboration with board-certified ophthalmologists and clinical research from the National Eye Institute, with manufacturing performed in a cGMP-certified, FDA-inspected U.S. facility.

The business operates a pure-play DTC model: products are sold exclusively through Vitrea's own Shopify-style e-commerce storefront in the United States, supported by digital-first marketing across blog content, email newsletter, and organic social channels (Facebook, Instagram, LinkedIn). The company has announced a forthcoming member ecosystem — including exclusive resources, community features, and digital tools for tracking eye health — to layer engagement onto the core supplement offering. Capital formation to date has been modest, with $120,000 of disclosed funding raised in July 2023.

Vitrea operates as an early-stage private company with 11-50 employees, no public financials, no app, no third-party distribution, and no disclosed customer logos. Its strategic challenge is converting awareness in a crowded nutraceutical category into a defensible, recurring-revenue member base ahead of larger incumbent supplement brands and pharmaceutical-affiliated AREDS lines.

Name

Vitrea Health

Legal name

Vitrea Health

Website

https://vitreahealth.com

Company type

Private

Founded year

2023

Operating status

Operating

Headcount range

11–50 employees

Short description

Vitrea Health is a U.S. direct-to-consumer startup that sells once-a-day eye health supplements — Vitrea Spectrum and Macular Restore — targeted at adults concerned with age-related macular degeneration, with a planned member community and digital eye-health tracking tools.

Ownership category

akta.pro rank

Product category

Eye Health Nutritional Supplements

NAICS

Food (Health) Supplement Retailers (456191)

SIC

Medicinal Chemicals & Botanical Products (2833)

akta.pro primary industry

Specialty Condition Supplements (Sleep, Stress, Heart, Joint, Gut, Immunity) (CRADAGAE)

akta.pro secondary industry

Healthy Aging & Cognitive Support Supplements (CRADAGAM)

Keywords

• Eye health supplements
• Macular degeneration supplements
• AREDS 2 formula
• Vision support supplements
• Nutritional eye care

Headquarters

HQ city

Detroit

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2C

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Personnel, Marketing or Sales, Operations, Technology or R&D

Revenue model

1. Direct Product Sales: Vitrea Health generates revenue through the direct sale of eye health supplements, including the Vitrea Vision Macular Restore and Vitrea Spectrum products. The company operates an e-commerce storefront selling once-a-day supplement products directly to consumers, with products like Macular Support available for purchase online.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels4 records

Core offering

Vitrea Health develops and sells advanced dietary supplements formulated to support macular health and combat age-related macular degeneration (AMD). Its products — Vitrea Spectrum® and Vitrea Vision Macular Restore — are once-a-day supplements combining AREDS-inspired ingredients with additional carotenoids, antioxidants, minerals, and amino acids such as Taurine, designed to cross the blood-retinal barrier, filter blue light, and counteract oxidative stress. Products are produced in a cGMP certified, FDA inspected US laboratory and formulated in collaboration with board-certified ophthalmologists, sold directly to consumers via the company's own e-commerce website.

Product overview

Vitrea Health offers a focused portfolio of advanced eye health supplements designed to combat macular degeneration. The company's flagship product, Vitrea Spectrum®, provides a broad-spectrum nutrient blend that goes beyond traditional AREDS formulas by incorporating additional carotenoids and antioxidants. Their core offering, Vitrea Vision Macular Restore, is a once-a-day supplement formulated in collaboration with board-certified ophthalmologists, targeting oxidative stress, nutritional deficiencies, and blue light damage. Both products share the same formulation approach, leveraging nature-derived nutrients that cross the blood-retinal barrier and are produced in a cGMP certified facility. The company also provides member-exclusive resources and digital tools for tracking eye health (coming soon).

Differentiator

Problem solved

Functional benefit

Products and services

• Vitrea Spectrum®

Quantifiable outcome

• Nutrients cross the blood-retinal barrier to deliver vision-supporting compounds directly to the target area
• +2 more outcomes

Segments1 record

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Recent moves5 records

Expansion highlights4 records

Direct peers

• MacuHealth: MacuHealth markets a proprietary triple-carotenoid (lutein, zeaxanthin, meso-zeaxanthin) supplement for macular pigment and AMD risk reduction, with published clinical trials. Direct competitor to Vitrea in the premium, science-led macular supplement segment.
• Bausch + Lomb (PreserVision AREDS 2): PreserVision AREDS 2 is the dominant, doctor-recommended eye health supplement for macular degeneration — the same exact clinical claim space (AREDS 2 formulation) that Vitrea is positioning against. This is the primary incumbent Vitrea must differentiate from.
• EyePromise (ScienceBased Health): EyePromise sells AREDS-based and macular health supplements through eye care professionals, directly competing with Vitrea's macular support category. Similar positioning (clinically formulated eye vitamins) with a stronger practitioner-channel focus.
• Life Extension: Life Extension sells an AREDS 2-based eye health supplement directly to consumers via its own e-commerce store, with a heavy clinical-citation marketing style similar to Vitrea's. A relevant DTC-only peer in the same channel.
• Carlson Labs: Carlson Labs markets lutein, zeaxanthin, and AREDS-style eye health supplements, including products positioned for macular support. Comparable single-condition eye-health supplement SKU with overlapping target demographic.

Broad incumbents

• Alcon (ICAPS / Vitalux): Alcon markets ICAPS and Vitalux ocular nutrition supplements as part of its broader ophthalmic portfolio. Comparable product category but backed by a global eye-care incumbent with deep optometrist relationships and pharmacy distribution.
• NOW Foods: NOW Foods offers a lutein/zeaxanthin-based eye health supplement at value pricing through its own DTC site and major retail. Comparable eye-health supplement category and a relevant incumbent benchmark on price/positioning.
• Nature's Bounty: Nature's Bounty sells a widely distributed eye health supplement containing lutein and zeaxanthin in major retail and online. Comparable product category, but operates as a mass-market CPG brand rather than a condition-focused specialist.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat3 records

Key risks6 records

Key highlights6 records

Customer concentration

• Facebookfacebook.com/people/Vitrea/61553190133982
• LinkedInlinkedin.com/company/vitrea-vision
• Instagraminstagram.com/vitreavision

Compliance2 records

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds1 record

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Vitrea Health